NCT02954926View on ClinicalTrials.gov

Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Neonatal Sepsis
Interventions
DRUG

IVIG

IVIG at a dose of 500mg/kg within 12 h and 3 days of birth

Trial Locations (1)

79176

Shahid Mohammadi hospital, Bandar Abbas

All Listed Sponsors
lead

Hormozgan University of Medical Sciences

OTHER

NCT02954926 - Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis | Biotech Hunter | Biotech Hunter